Literature DB >> 24855004

The microbiome and obesity-an established risk for certain types of cancer.

Connie J Rogers1, Kumble Sandeep Prabhu, Matam Vijay-Kumar.   

Abstract

Obesity is a major modifiable risk factor for the development of numerous types of cancer. Although many factors contribute to obesity-driven tumorigenesis, this review focuses on the functioning of the gut microbiota (the microbiome) as an environmental risk factor for certain types of cancers, and presents possible biological mediators. Obesity is a well-studied condition that is associated with microbiotal dysbiosis, which could result in several physiologic changes that may contribute to the relationship between obesity and cancer risk. These include altered microbial metabolism, which contributes to the generation of procarcinogenic toxic metabolites; increased extraction of energy and nutrient availability leading to metabolic dysregulation that contributes to tumor growth; and/or the induction of subclinical inflammation initiating tumorigenesis. Thus, the gut microbiota may serve as a key link between obesity and cancer and, therefore, viable strategies to alter the microbiota may provide novel therapeutics to reduce obesity-associated cancer risk.

Entities:  

Mesh:

Year:  2014        PMID: 24855004     DOI: 10.1097/PPO.0000000000000049

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  27 in total

Review 1.  The intestinal microbiota: its role in health and disease.

Authors:  Luc Biedermann; Gerhard Rogler
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

2.  Evidence for a link between gut microbiota and hypertension in the Dahl rat.

Authors:  Blair Mell; Venkatakrishna R Jala; Anna V Mathew; Jaeman Byun; Harshal Waghulde; Youjie Zhang; Bodduluri Haribabu; Matam Vijay-Kumar; Subramaniam Pennathur; Bina Joe
Journal:  Physiol Genomics       Date:  2015-03-31       Impact factor: 3.107

Review 3.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

Review 4.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

Review 5.  Translating Mechanism-Based Strategies to Break the Obesity-Cancer Link: A Narrative Review.

Authors:  Laura A Smith; Ciara H O'Flanagan; Laura W Bowers; Emma H Allott; Stephen D Hursting
Journal:  J Acad Nutr Diet       Date:  2018-04       Impact factor: 4.910

Review 6.  Human Microbiome Engineering: The Future and Beyond.

Authors:  Arunava Kali
Journal:  J Clin Diagn Res       Date:  2015-09-01

7.  Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.

Authors:  Virginia K Clements; Tiha Long; Ramses Long; Chas Figley; Daniel M C Smith; Suzanne Ostrand-Rosenberg
Journal:  J Leukoc Biol       Date:  2018-01-03       Impact factor: 4.962

Review 8.  Expected and paradoxical effects of obesity on cancer treatment response.

Authors:  Marco Gallo; Valerio Adinolfi; Viola Barucca; Natalie Prinzi; Valerio Renzelli; Luigi Barrea; Paola Di Giacinto; Rosaria Maddalena Ruggeri; Franz Sesti; Emanuela Arvat; Roberto Baldelli; Emanuela Arvat; Annamaria Colao; Andrea Isidori; Andrea Lenzi; Roberto Baldell; M Albertelli; D Attala; A Bianchi; A Di Sarno; T Feola; G Mazziotti; A Nervo; C Pozza; G Puliani; P Razzore; S Ramponi; S Ricciardi; L Rizza; F Rota; E Sbardella; M C Zatelli
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

9.  Deep Transcranial Magnetic Stimulation Affects Gut Microbiota Composition in Obesity: Results of Randomized Clinical Trial.

Authors:  Anna Ferrulli; Lorenzo Drago; Sara Gandini; Stefano Massarini; Federica Bellerba; Pamela Senesi; Ileana Terruzzi; Livio Luzi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 10.  Repurposing metformin for the treatment of gastrointestinal cancer.

Authors:  Ademar Dantas Cunha Júnior; Arinilda Campos Bragagnoli; Felipe Osório Costa; José Barreto Campello Carvalheira
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.